The 13 C‐methactin breath test is non‐inferior to liver biopsy in predicting liver‐related death and transplantation: A 7‐year prospective follow‐up study in 132 patients with chronic hepatitis C infection-Reference-Cited by-同舟云学术

The 13 C‐methactin breath test is non‐inferior to liver biopsy in predicting liver‐related death and transplantation: A 7‐year prospective follow‐up study in 132 patients with chronic hepatitis C infection

Published:2020-11 Issue:6 Volume:2 Page:344-350
ISSN:1478-1239
Container-title:GastroHep
language:en
Short-container-title:GastroHep

Author:

Goetze Oliver¹²^ORCID,Breuer Monika¹,Geier Andreas¹²,Fried Michael¹,Weber Achim³,Jochum Wolfram⁴,Ilan Yaron⁵^ORCID,Mullhaupt Beat¹^ORCID

Affiliation:

1. Swiss HPB (Hepato‐Pancreato‐Biliary) Centre and Division of Gastroenterology and Hepatology University Hospital Zurich Zurich Switzerland

2. Division of Hepatology University Hospital Würzburg Wurzburg Germany

3. Department of Pathology and Molecular Pathology University Hospital Zurich Zurich Switzerland

4. Institute of Pathology Kantonsspital St. Gallen Switzerland

5. Liver Unit Department of Medicine Hebrew University‐Hadassah Medical Centre Jerusalem Israel

Publisher

Hindawi Limited

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ygh2.430

Reference52 articles.

1. Selection for acute liver failure: Have we got it right?

2. How much liver resection is too much?

3. Model for end-stage liver disease (MELD) for liver allocation: A 5-year score card

4. The model for end-stage liver disease (MELD)

5. Assessment of Prognosis of Cirrhosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical application of breath tests in disorders of gut–brain interaction;Current Opinion in Pharmacology;2022-08

2. European guideline on indications, performance and clinical impact of 13 C‐breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC;United European Gastroenterology Journal;2021-06